Coupons & Offers
Highlights
composition with strength
Omega-3 Fatty Acid (300mg)
description
Effective antihistamine for eye allergies, provides quick relief from itching and redness, helps prevent future allergic reactions, easy application with dropper
key benefits
Nutritional deficiencies
side effects
Nausea, Vomiting and Flatulence
how to use
Take this medicine in the exact dose and duration as prescribed by your doctor
alcohol interaction
Unsafe
pregnancy interaction
Consult Your Doctor
lactation interaction
Consult Your Doctor
driving interaction
Safe
kidney interaction
Consult Your Doctor
liver interaction
Consult Your Doctor
Information
disclaimer
The contents and images displayed on this Platform are for informational purposes only and are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a registered medical practitioner with any questions you may have regarding a medical condition or the use of any product. Do not disregard professional medical advice or delay seeking it because of something you have read on this Platform.We intend to support, not replace, the doctor-patient relationship.
While we make every effort to ensure the information provided is accurate and up-to-date, we strongly recommend reviewing product labels, batch numbers, manufacturing and packaging details, as well as any warnings and usage instructions before using or consuming any product.
customer care details
In case of any issue, contact us
E-mail address: support@zeptonow.com
Seller Name
Drogheria Sellers Private Limited
Seller Address
Brigade IRV, 9th & 10th Floors, Nallurhalli, White Field, Bangalore, Banglore, Karnataka, India, 560066 For Support ReachOut : support+drogheria@zeptonow.com
Pharmacy License No.
MH-TZ1-581061, MH-TZ1-581062
Manufacturer or Marketer Name
Allergan India Private Limited
Manufacturer or Marketer Address
No.3, Kasturba Road, Level 2, Prestige Obelisk, Bangalore 560 001., KARNATAKA, INDIA
Country of Origin
India
Shelf Life
24 months
Expires on or after
November 2026
